Mercer Brian M
Reproductive Biology, Case Western Reserve University and Department of Obstetrics & Gynecology, MetroHealth Medical Center, Cleveland, OH 44109, USA.
Clin Obstet Gynecol. 2007 Jun;50(2):487-96. doi: 10.1097/GRF.0b013e31804c977d.
Conservative management of preterm premature rupture of the membranes (pPROM) remote from term has been associated with significant pregnancy prolongation and has been shown to reduce infant complications when prophylactic antibiotics and antenatal corticosteroids are given concurrently. However, the majority of conservatively managed women with pPROM will deliver within 1 week and do not accrue the benefits of extended pregnancy prolongation. The utility of tocolytic therapy after pPROM remains controversial, but 2 recent surveys of clinician practice revealed frequent utilization of tocolysis after pPROM, with magnesium sulfate being the most commonly used agent. In this manuscript, we review the currently available literature regarding the efficacy, risks, and benefits of tocolytic therapy during conservative management of preterm PROM remote from term.
孕晚期胎膜早破(pPROM)的保守治疗与显著延长孕周相关,并且已表明在同时给予预防性抗生素和产前糖皮质激素时可减少婴儿并发症。然而,大多数接受保守治疗的pPROM女性会在1周内分娩,无法获得延长孕周的益处。pPROM后使用宫缩抑制剂治疗的效用仍存在争议,但最近两项临床医生实践调查显示,pPROM后经常使用宫缩抑制剂,硫酸镁是最常用的药物。在本手稿中,我们回顾了目前关于孕晚期pPROM保守治疗期间宫缩抑制剂治疗的疗效、风险和益处的现有文献。